Miglustat hydrochloride NEW
| Price | $34 | $80 | $139 |
| Package | 1mg | 5mg | 10mg |
| Supply Ability: | 10g |
| Update Time: | 2026-06-02 |
Product Details
| Product Name: Miglustat hydrochloride | CAS No.: 210110-90-0 |
| Purity: 99.85% | Supply Ability: 10g |
| Release date: 2026/06/02 |
Product Introduction
Bioactivity
| Name | Miglustat hydrochloride |
| Description | Miglustat hydrochloride (N-Butyldeoxynojirimycin hydrochloride) is an inhibitor of glucosylceramide synthase and can be used for studies about Type I Gaucher disease. |
| In vivo | Consumption of a standard high-fat breakfast within 30 minutes before administration of Miglustat hydrochloride significantly reduced peak exposure but did not significantly affect the extent of systemic exposure to Miglustat hydrochloride. The Cmax decreased by 36% on average following administration with food. AUC showed a modest (14%) decrease with food, but the 90% confidence interval was within the acceptance limit of 80% to 125%. Tmax was prolonged from 2.5 (1.0-4.0) hours in the fasted state to 4.5 (1.5-8.0) hours in the fed state, whereas the apparent terminal half-life was approximately 8 hours and not affected by food[1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | H2O : 34 mg/mL (132.95 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2.5 mg/mL (9.78 mM), Sonication is recommended. DMSO : 122.5 mg/mL (479 mM), Sonication is recommended. 10% DMSO+90% Saline : 10 mg/mL (39.1 mM), Solution. |
| Keywords | type I gaucher disease | oral | OGT-918 Hydrochloride | OGT918 Hydrochloride | OGT-918 | OGT918 | OGT 918 Hydrochloride | OGT 918 | N-Butyldeoxynojirimycin Hydrochloride | N-Butyldeoxynojirimycin | NB-DNJ Hydrochloride | NB-DNJ | Miglustat hydrochloride | Miglustat | Inhibitor | inhibit | Glucosylceramide Synthase (GCS) | glucosylceramide synthase | ceramide glucosyltransferase |
| Inhibitors Related | Alendronate sodium trihydrate | Serotonin hydrochloride | Serotonin | D(+)-Raffinose pentahydrate | Risedronic Acid | 3-Methoxybenzamide | Entacapone | CBHcy | Eliglustat hemitartrate | (-)-Gallocatechin gallate | Flopropione | Tolcapone |
| Related Compound Libraries | Bioactive Compound Library | Approved Drug Library | Drug-induced Liver Injury (DILI) Compound Library | EMA Approved Drug Library | Toxic Compound Library | Drug Repurposing Compound Library | Inhibitor Library | FDA-Approved Drug Library | Metabolism Compound Library | Orally Active Compound Library | Bioactive Compounds Library Max | NMPA-Approved Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
-
CAS:54-71-7
-
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $38.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-05-11 | |
| $2.00 |
VIP2Y
|
ZHENGZHOU JIUYI TIME NEW MATERIALS CO,.LTD
|
2026-04-17 | |
|
VIP4Y
|
Dingwang Technology (Wuhan) Co., Ltd.
|
2025-08-22 | ||
| $10.00 |
Ouhuang Engineering Materials (Hubei) Co., Ltd
|
2024-04-25 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY